abstract |
Disclosed are hydroxamate derivatives of formula (I) that are inhibitors of histone deacetylase and therefore useful in the treatment of diseases associated with histone deacetylase activity, such as cancer. Pharmaceutical compositions and processes for preparing these compounds are also disclosed. |